Drug Shortage Report for CISPLATIN INJECTION, BP

Last updated on 2024-10-26 History
Report ID 225228
Drug Identification Number 02355183
Brand name CISPLATIN INJECTION, BP
Common or Proper name CISPLATIN
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) CISPLATIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 50ML
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-06-18
Estimated end date 2024-10-25
Actual end date 2024-10-25
Shortage status Resolved
Updated date 2024-10-26
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2024-10-26 English Compare
v24 2024-10-25 French Compare
v23 2024-10-25 English Compare
v22 2024-10-11 French Compare
v21 2024-10-11 English Compare
v20 2024-09-27 French Compare
v19 2024-09-27 English Compare
v18 2024-09-20 French Compare
v17 2024-09-20 English Compare
v16 2024-08-30 French Compare
v15 2024-08-30 English Compare
v14 2024-07-19 French Compare
v13 2024-07-19 English Compare
v12 2024-07-12 French Compare
v11 2024-07-12 English Compare
v10 2024-06-19 English Compare
v9 2024-06-14 French Compare
v8 2024-06-14 English Compare
v7 2024-06-07 French Compare
v6 2024-06-07 English Compare

Showing 1 to 20 of 25